Generic Name:
deferiprone
Project Status:
Active
Therapeutic Area:
Transfusional iron overload
Manufacturer:
Chiesi Canada Corp.
Brand Name:
Ferriprox
Project Line:
Reimbursement Review
Project Number:
SR0741-000
NOC Status at Filing:
Post NOC
Details
Manufacturer Requested Reimbursement Criteria1:
For the treatment of patients with transfusional iron overload due to sickle cell disease or other anemias.
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
For the treatment of patients with transfusional iron overload due to sickle cell disease or other anemias.
Date NOC Issued:
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.